Celladon to Report Fourth Quarter and Fiscal 2014 Results on March 31
March 25, 2015 16:04 ET
|
Celladon Corporation
SAN DIEGO, March 25, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Novasep and Celladon Execute MYDICAR API Supply Agreement
March 24, 2015 16:05 ET
|
Celladon Corporation
SAN DIEGO and POMPEY, France, March 24, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage cardiovascular gene therapy company and Novasep, a leading supplier of services...
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 16, 2015 07:00 ET
|
Celladon Corporation
SAN DIEGO, March 16, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation to Present at the BIO CEO & Investor Conference
February 03, 2015 07:00 ET
|
Celladon Corporation
SAN DIEGO, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 09, 2015 08:00 ET
|
Celladon Corporation
SAN DIEGO, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation Conducts Initial Scale Up of Manufacturing Process for MYDICAR to Commercial Scale
January 05, 2015 07:00 ET
|
Celladon Corporation
SAN DIEGO, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation Added to NASDAQ Biotechnology Index
December 16, 2014 08:00 ET
|
Celladon Corporation
SAN DIEGO, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation to Present at 11th Global Cardio Vascular Clinical Trial Forum
December 01, 2014 16:10 ET
|
Celladon Corporation
SAN DIEGO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Selected to Present During the "Best of Circulation Research" Symposium at the American Heart Association Scientific Sessions 2014
November 14, 2014 08:00 ET
|
Celladon Corporation
SAN DIEGO, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Reports Third Quarter 2014 Financial Results and Recent Highlights
November 12, 2014 06:00 ET
|
Celladon Corporation
SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...